These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14562817)

  • 1. Transdermal clonidine. Patching up errors.
    Cohen MR
    Nursing; 2003 Sep; 33(9):12. PubMed ID: 14562817
    [No Abstract]   [Full Text] [Related]  

  • 2. Utility of a transdermal delivery system for antihypertensive therapy. Part 2.
    Sclar DA; Skaer TL; Chin A; Okamoto MP; Gill MA
    Am J Med; 1991 Jul; 91(1A):57S-60S. PubMed ID: 1907802
    [No Abstract]   [Full Text] [Related]  

  • 3. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R; Tagawa T; Ishida T; Naruse T
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of transdermal clonidine in chronic hemodialysis patients.
    Rosansky SJ; Johnson KL; McConnell J
    Clin Nephrol; 1993 Jan; 39(1):32-6. PubMed ID: 8428405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin depigmentation related to transdermal clonidine therapy.
    Doe N; Seth S; Hebert LA
    Arch Intern Med; 1995 Oct; 155(19):2129. PubMed ID: 7575076
    [No Abstract]   [Full Text] [Related]  

  • 6. Transcription medication error with transdermal clonidine.
    Mallet L; Cooper JW
    South Med J; 1988 Dec; 81(12):1597-8. PubMed ID: 3201308
    [No Abstract]   [Full Text] [Related]  

  • 7. Utility of a transdermal delivery system for antihypertensive therapy. Part 1.
    Sclar DA; Skaer TL; Chin A; Okamoto MP; Gill MA
    Am J Med; 1991 Jul; 91(1A):50S-56S. PubMed ID: 1907801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transdermal treatment of hypertension].
    Rosenfeld J
    Harefuah; 1988 Feb; 114(4):210-1. PubMed ID: 3356394
    [No Abstract]   [Full Text] [Related]  

  • 9. Allergic contact dermatitis from transdermal clonidine in a patient with mycosis fungoides.
    Polster AM; Warner MR; Camisa C
    Cutis; 1999 Mar; 63(3):154-5. PubMed ID: 10190065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin reactions to clonidine: not just a local problem. Case report.
    Crivellaro MA; Bonadonna P; Dama A; Senna G; Passalacqua G
    Allergol Immunopathol (Madr); 1999; 27(6):318-9. PubMed ID: 10611557
    [No Abstract]   [Full Text] [Related]  

  • 11. Intentional clonidine patch ingestion by 3 adults in a detoxification unit.
    Rapko DA; Rastegar DA
    Arch Intern Med; 2003 Feb; 163(3):367-8. PubMed ID: 12578519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Cloniderm" toxicity: another manifestation of clonidine overdose.
    Killian CA; Roberge RJ; Krenzelok EP; Stonage CL
    Pediatr Emerg Care; 1997 Oct; 13(5):340-1. PubMed ID: 9368249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case 1: A Medically Complex 10-month-old Boy with Lethargy.
    Toce MS; Lyons TW
    Pediatr Rev; 2019 Feb; 40(2):79-81. PubMed ID: 30709974
    [No Abstract]   [Full Text] [Related]  

  • 14. Antihypertensive effects of a new transdermal delivery system for clonidine (M-5041T) in spontaneously hypertensive rats.
    Ishii R; Naruse T; Tagawa T; Yamahata T; Dote S; Hamada K; Ishida T; Funabiki K; Namba K
    Arch Int Pharmacodyn Ther; 1994; 327(3):294-308. PubMed ID: 7848013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indapamide regresses, but transdermal clonidine does not regress, left ventricular hypertrophy in hypertensive diabetic patients.
    Tan SA; Berk LS; Tan LG
    Am J Cardiol; 1996 Feb; 77(6):20B-22B. PubMed ID: 8848989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose linearity of clonidine after transdermal application.
    Wallenstein G; Gladigau V
    Clin Auton Res; 1993 Dec; 3(6):369-72. PubMed ID: 8193523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Randomized double-blind controlled study on treatment of tic disorders in children with transcutaneous patch of clonidine].
    Zhong YQ; Zhou WZ; Hu WG
    Zhonghua Er Ke Za Zhi; 2007 Oct; 45(10):785-7. PubMed ID: 18211768
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma dilution during transdermal clonidine antihypertensive monotherapy.
    Zawada ET; Jensen RA; Williams L; Zeigler DW; Kauker ML
    Int J Artif Organs; 1989 Mar; 12(3):200-3. PubMed ID: 2744881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal clonidine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
    Langley MS; Heel RC
    Drugs; 1988 Feb; 35(2):123-42. PubMed ID: 3281820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioequivalence and adhesion evaluation of transdermal clonidine following a change in excipient supplier.
    Ehrlich J; Beck B; Thiedmann R; Marzin K; MacGregor T
    Int J Clin Pharmacol Ther; 2016 Oct; 54(10):816-24. PubMed ID: 27390050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.